LifeMine

LifeMine is the first company to massively scale up genomic discovery of powerful new drug models from eukaryotic microorganisms. Our integrated, genome-based drug discovery engine is poised to deliver a range of drugs that will overcome previously insurmountable human diseases. LifeMine's proprietary platform promises to address this industry challenge. At this biotech innovator, the research team organically integrates genomics, artificial intelligence, and synthetic biology to modify the functions of genes responsible for biosynthesis, making rapid drug discovery possible. They are well-positioned to discover potent new drugs in fungi that target previously "undruggable" disease targets.